All news

ADM shares rise on CJ CheilJedang amino acid venture

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

Archer-Daniels-Midland shares rose 1.17% after the company announced a new amino acid joint venture with CJ CheilJedang aimed at improving feed-grade amino acid supply in the Americas. CJ CheilJedang will be the majority owner, while ADM contributes assets and feedstock capabilities. The stock closed at USD 80.45, above the average analyst target of USD 79.67, despite positive second-quarter 2026 financial results.

Read original source

ADM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.